Euro Biosimilars 2019

About Conference

The Organizing Committee is delighted to invite you to attend the 12^th European Biosimilars Congress one of its remarkable Pharmaceutical conferences, to be held during April 15-16, 2019 in Berlin, Germany. European Biosimilars Congress is a global annual event. This European Biosimilars Congress 2019 will bring together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.

Conference Highlights

Current Challenges in Developing Biosimilars

Analytical Strategies for Biosimilars

Intellectual Property Rights

Biological Medicine

Emerging Biosimilars in Therapeutics

Innovative Clinical Approach in Biosimilars

Regulatory Updates on Biosimilars

Biosimilars Development in Markets

Biosimilars Approval to Biogenerics in Clinical Practice

Biopharmaceutical Informatics

Consequences of Brexit on Biosimilars

BCS and IVIVC Based Biowaivers

Biosimilars Market and Cost Analysis

Challenges in Biosimilars Pharmacovigilance

Legal Issues and BPCI Act

Formulation Strategies for Follow-on Biologics

Current Agency Expectations for Approval for Biosimilars

Biosimilars Research Pipeline

Globalization of Biosimilars

Drug Delivery and Development

Monoclonal Antibody Biosimilars

USFDA Approved Biosimilars

 Supported by

Journal of Bioanalysis & Biomedicine 

 Journal of Bioequivalence & Bioavailability 

 Journal of Pharmaceutical Sciences & Emerging Drugs

All accepted abstracts will be published in respective Conference series International Journals.

Abstracts will be provided with Digital Object Identifier by Crossref